DSP Healthcare Fund

The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies/entities.

Growthvine rating: 5/5 — ranked #6 of 87 in category.

Fund basics

CategoryEquity: Sectoral
NAV₹46.83 (as of 2026-11-13)
AUM₹3,750 Cr
Expense ratio1.64%
RiskometerVery High
Fund managerChirag Dagli
Exit load0.5% for redemption within 1 month

Performance & risk

5-year annualised return14.36%
Sharpe ratio0.93
Standard deviation15.05%
Max drawdown−22.08%
Alpha-0.47
Beta0.86

Over 5 years, captured 87.8% of NIFTY Pharma's upside and 83.0% of its downside.

Market cap allocation

Large cap30.6%
Mid cap16.3%
Small cap53.1%

Concentration

Top 5 holdings36.7%
Top 10 holdings61.2%
Total holdings33

Top holdings

Top sectors

Calendar-year track record

YearReturnQuartileCategory rank
2026 (partial)19.5%Q1 (Top)#11 of 76
2025−5.8%Q4 (Bottom)#61 of 69
202440.7%Q1 (Top)#8 of 58
202335.0%Q3#27 of 48
2022−7.8%Q3#34 of 46